⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
C3a–C3AR1 Complement Signalling in Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-09 — Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.: 2026 narrative review consolidates scattered animal, human-cohort, and disease-model evidence to position chronic C3a–C3AR1 signalling as an ageing-sensitive axis that reprograms macrophages and microglia, drives immunometabolic and endothelial dysfunction, and shows the strongest chronological-ageing signal in visceral adipose tissue and the neurovascular unit — synthesis, no new primary data, and flags systemic C3AR1 inhibition as facing context-dependent safety trade-offs. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.
09-sep-2026
novelty 3
per-area 3
strengthens